John Tilton Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John Tilton.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John Tilton. John Tilton is CCO-Rare & Neurologic Disorder in Biohaven Pharmaceutical Holding Co Ltd. ($BHVN) and Chief Commercial Officer in Biohaven Pharmaceutical Holding Co Ltd. ($BHVN).
Latest Insider Trading Transactions of John Tilton
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | A | 83.38 | 10,000 | 833,800 | 10,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Payment of Exercise | F | 83.38 | 492 | 41,023 | 2,659 | 3.2 K to 2.7 K (-15.61 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | M | 0.00 | 1,250 | 0 | 3,151 | 1.9 K to 3.2 K (+65.75 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | A | 83.38 | 10,000 | 833,800 | 10,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Payment of Exercise | F | 83.38 | 492 | 41,023 | 2,659 | 3.2 K to 2.7 K (-15.61 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | M | 0.00 | 1,250 | 0 | 3,151 | 1.9 K to 3.2 K (+65.75 %) |
| Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,250 | 0 | 2,500 | |
| Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Payment of Exercise | F | 90.14 | 480 | 43,267 | 1,540 | 2 K to 1.5 K (-23.76 %) |
| Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | M | 0.00 | 1,250 | 0 | 2,020 | 770 to 2 K (+162.34 %) |
| Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,250 | 0 | 2,500 | |
| Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Payment of Exercise | F | 90.14 | 480 | 43,267 | 1,540 | 2 K to 1.5 K (-23.76 %) |
| Nov 27 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | M | 0.00 | 1,250 | 0 | 2,020 | 770 to 2 K (+162.34 %) |
| Jun 12 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | M | 9.29 | 52,000 | 483,080 | 37,292 | |
| Jun 12 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Sell | S | 69.40 | 2,467 | 171,202 | 770 | 3.2 K to 770 (-76.21 %) |
| Jun 12 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Sell | S | 68.57 | 5,331 | 365,528 | 3,237 | 8.6 K to 3.2 K (-62.22 %) |
| Jun 12 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Sell | S | 67.53 | 22,838 | 1,542,234 | 8,568 | 31.4 K to 8.6 K (-72.72 %) |
| Jun 12 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Sell | S | 66.70 | 21,364 | 1,425,036 | 31,406 | 52.8 K to 31.4 K (-40.49 %) |
| Jun 12 2020 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | M | 9.29 | 52,000 | 483,080 | 52,770 | 770 to 52.8 K (+6,753.25 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | CCO-Rare & Neurolog ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | CCO-Rare & Neurolog ... | Payment of Exercise | F | 52.13 | 480 | 25,022 | 770 | 1.3 K to 770 (-38.40 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | CCO-Rare & Neurolog ... | Buy | M | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | CCO-Rare & Neurolog ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | CCO-Rare & Neurolog ... | Payment of Exercise | F | 52.13 | 480 | 25,022 | 770 | 1.3 K to 770 (-38.40 %) |
| Dec 20 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | CCO-Rare & Neurolog ... | Buy | M | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K |
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | CCO-Rare & Neurolog ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Nov 27 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | CCO-Rare & Neurolog ... | Option Exercise | A | 57.40 | 10,000 | 574,000 | 10,000 | |
| Mar 14 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | M | 9.29 | 10,000 | 92,900 | 78,792 | |
| Mar 14 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Sell | S | 50.11 | 10,000 | 501,100 | 0 | 10 K to 0 (-100.00 %) |
| Mar 14 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | M | 9.29 | 10,000 | 92,900 | 10,000 | 0 to 10 K |
| Jan 14 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | M | 9.29 | 10,500 | 97,545 | 10,500 | |
| Jan 14 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Sell | S | 37.67 | 10,500 | 395,535 | 0 | 10.5 K to 0 (-100.00 %) |
| Jan 14 2019 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | M | 9.29 | 10,500 | 97,545 | 10,500 | 0 to 10.5 K |
| Dec 11 2017 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | A | 20.79 | 21,740 | 451,975 | 21,740 | |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | M | 9.29 | 30,000 | 278,700 | 88,792 | |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Sell | S | 29.63 | 8,653 | 256,388 | 0 | 8.7 K to 0 (-100.00 %) |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Sell | S | 29.10 | 21,347 | 621,198 | 8,653 | 30 K to 8.7 K (-71.16 %) |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | M | 9.29 | 30,000 | 278,700 | 30,000 | 0 to 30 K |
| May 11 2017 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | C | 0.00 | 1,614 | 0 | 0 | |
| May 11 2017 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | C | 0.00 | 1,614 | 0 | 1,614 | 0 to 1.6 K |
Page: 1